Skip to main content
Top

Current Breast Cancer Reports

Issue 2/2023

Content (10 Articles)

Pictorial Review of Male Breast Disease

Spencer Wehring, Ashley Roark, Alfred Watson Jr, Tamara Ortiz-Perez

Intramammary Metastases from Extramammary Malignancies: An Update

Cortlandt M. Sellers, Tamara Ortiz-Perez, Sagar Dhamne, Ashley Roark, Luke Gilman

Supplemental Screening for Breast Cancer

Charles De Jesus, Tanya W. Moseley, Valentina Diaz, Varnita Vishwanath, Shanen Jean, Ahmed Elhatw, Hanna R. Ferreira Dalla Pria, Hannah L. Chung, Mary S. Guirguis, Miral M. Patel

The Benefits of Screening Mammography

Charles De Jesus, Tanya W. Moseley, Valentina Diaz, Varnita Vishwanath, Shanen Jean, Ahmed Elhatw, Hanna R. Ferreira Dalla Pria, Hannah L. Chung, Mary S. Guirguis, Miral M. Patel

Advanced Breast Imaging Modalities — DBT, CEM, MBI, PEM, MRI, AI

Ahmed Elhatw, Hannah L. Chung, Rasha M. Kamal, Charles De Jesus, Shanen Jean, Varnita Vishwanath, Hanna R. Ferreira Dalla Pria, Miral M. Patel, Mary S. Guirguis, Tanya W. Moseley

Identifying and Reducing Barriers to Breast Imaging

Shanen Jean, Varnita Vishwanath, Hannah L. Chung, Tanya W. Moseley

Breast Imaging Considerations in Symptomatic Young, Pregnant, and Lactating Women

Hannah L. Chung, Jana Joiner, Hanna R. Ferreira Dalla Pria, Shanen Jean, Varnita Vishwanath, Charles De Jesus, Ahmed Elhatw, Mary S. Guirguis, Miral M. Patel, Tanya W. Moseley

Mastectomy Clinical Trial Report

Robot-assisted Nipple Sparing Mastectomy: Recent Advancements and Ongoing Controversies

Ko Un Park, Chihwan Cha, Giada Pozzi, Young-Joon Kang, Vanesa Gregorc, Anna Sapino, Guglielmo Gazzetta, Emilia Marrazzo, Antonio Toesca

Breast Cancer Clinical Trial Report

Current Updates in Management of HER2-Positive and HER2-Low Breast Cancer

Arushi Thaper, Jennifer Tran, Azka Ali

Open Access Metastasis Clinical Trial Report

Breast-to-Brain Metastasis: from Microenvironment to Plasticity

Diganta Das, Mukund Iyer, Evanthia T. Roussos Torres, Frances E. Chow, Josh Neman

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine